共 50 条
- [2] BRAF inhibition by vemurafenib in combination with temozolomide or fotemustine in melanoma cells [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 27 - 27
- [4] Cytotoxicity through BRaf inhibition by vemurafenib in combination with temozolomide or fotemustine in melanoma cells [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 53 - 53
- [7] High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
- [8] High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study [J]. Journal of Translational Medicine, 8
- [10] Ipilimumab with fotemustine in metastatic melanoma [J]. LANCET ONCOLOGY, 2012, 13 (09): : 851 - 852